Andy Sassine is Chief Financial Officer of Arcturus Therapeutics Holdings Inc.. Currently has a direct ownership of 220,526 shares of ARCT, which is worth approximately $3.64 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 50,000 shares (Common Stock) at a price of $32.03 per share, resulting in proceeds of $1,601,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K
0% 3M change
18.48% 12M change
Total Value Held $3.64 Million

ANDY SASSINE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
SELL
Open market or private sale
$1,601,500 $32.03 p/Share
50,000 Reduced 18.48%
220,526 Common Stock
Aug 15 2023
BUY
Grant, award, or other acquisition
$21,243 $17.37 p/Share
1,223 Added 0.45%
270,526 Common Stock
Aug 15 2022
BUY
Grant, award, or other acquisition
$19,673 $18.42 p/Share
1,068 Added 0.4%
269,303 Common Stock

Also insider at

ICAD
ICAD INC Healthcare
XCUR
EXICURE, INC. Healthcare
AS

Andy Sassine

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on ARCT

Follow Arcturus Therapeutics Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARCT shares.

Notify only if

Insider Trading

Get notified when an Arcturus Therapeutics Holdings Inc. insider buys or sells ARCT shares.

Notify only if

News

Receive news related to Arcturus Therapeutics Holdings Inc.

Track Activities on ARCT